FDA Approves First Ebola Virus Treatment

THURSDAY, Oct. 15, 2020 — The first drug for Zaire ebolavirus (Ebola virus) infection has been approved for adults and children, the U.S. Food and Drug Administration announced Wednesday.
Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) is a…
Source: Topamax